Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) where a protected aminoalkylpiperidine moiety is required. Its Boc-protected amine group allows for selective deprotection and further functionalization in multi-step organic syntheses. Commonly employed in the preparation of bioactive molecules, including CNS agents and receptor modulators, due to the piperidine ring’s prevalence in drug-like structures. The compound’s stability and solubility profile make it suitable for use in various coupling reactions, especially in solid-phase and solution-phase peptide-like synthesis.